AU3391200A - Compositions and methods for breast cancer therapy and diagnosis - Google Patents
Compositions and methods for breast cancer therapy and diagnosisInfo
- Publication number
- AU3391200A AU3391200A AU33912/00A AU3391200A AU3391200A AU 3391200 A AU3391200 A AU 3391200A AU 33912/00 A AU33912/00 A AU 33912/00A AU 3391200 A AU3391200 A AU 3391200A AU 3391200 A AU3391200 A AU 3391200A
- Authority
- AU
- Australia
- Prior art keywords
- diagnosis
- compositions
- methods
- breast cancer
- cancer therapy
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 206010006187 Breast cancer Diseases 0.000 title 1
- 208000026310 Breast neoplasm Diseases 0.000 title 1
- 238000003745 diagnosis Methods 0.000 title 1
- 238000000034 method Methods 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
- 238000011275 oncology therapy Methods 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/82—Translation products from oncogenes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/515—Animal cells
- A61K2039/5156—Animal cells expressing foreign proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/53—DNA (RNA) vaccination
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Analytical Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Wood Science & Technology (AREA)
- Immunology (AREA)
- Oncology (AREA)
- Pathology (AREA)
- Gastroenterology & Hepatology (AREA)
- Toxicology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Hospice & Palliative Care (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Physics & Mathematics (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US26250599A | 1999-03-04 | 1999-03-04 | |
| US09262505 | 1999-03-04 | ||
| US27288699A | 1999-03-19 | 1999-03-19 | |
| US09272886 | 1999-03-19 | ||
| US39631399A | 1999-09-17 | 1999-09-17 | |
| US09396313 | 1999-09-17 | ||
| PCT/US2000/005431 WO2000052165A2 (en) | 1999-03-04 | 2000-02-29 | Compositions and methods for breast cancer therapy and diagnosis |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU3391200A true AU3391200A (en) | 2000-09-21 |
Family
ID=27401517
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU33912/00A Abandoned AU3391200A (en) | 1999-03-04 | 2000-02-29 | Compositions and methods for breast cancer therapy and diagnosis |
Country Status (2)
| Country | Link |
|---|---|
| AU (1) | AU3391200A (en) |
| WO (1) | WO2000052165A2 (en) |
Families Citing this family (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PT2266603E (en) | 2000-10-18 | 2012-11-02 | Glaxosmithkline Biolog Sa | Tumour vaccines |
| EP1472285A2 (en) * | 2001-01-16 | 2004-11-03 | Incyte Genomics, Inc. | Secretory molecules |
| EP1227106A1 (en) * | 2001-01-26 | 2002-07-31 | Boehringer Ingelheim International GmbH | Pro-apoptotic proteins and DNA molecules encoding them |
| GB0109297D0 (en) | 2001-04-12 | 2001-05-30 | Glaxosmithkline Biolog Sa | Vaccine |
| US20050118582A1 (en) * | 2001-07-12 | 2005-06-02 | Anita Swarnakar | Nucleic acid-associated proteins |
| US20050123925A1 (en) | 2002-11-15 | 2005-06-09 | Genentech, Inc. | Compositions and methods for the diagnosis and treatment of tumor |
| US7544767B2 (en) * | 2002-04-05 | 2009-06-09 | Burnham Institute For Medical Research | HMGN2 peptides and related molecules that selectively home to tumor blood vessels and tumor cells |
| US7723018B2 (en) * | 2002-08-30 | 2010-05-25 | Rigel Pharmaceuticals, Incorporated | Methods of assaying for cell cycle modulators using components of the ubiquitin ligation cascade |
| WO2005049846A2 (en) | 2003-11-17 | 2005-06-02 | Crusade Laboratories Limited | Mutant herpes simplex virus and use thereof in the treatment of squamous cell cancer |
| US7371384B2 (en) | 2004-07-20 | 2008-05-13 | Genentech, Inc. | Compositions and methods of using angiopoietin-like 4 protein antibody |
| EP1771474B1 (en) | 2004-07-20 | 2010-01-27 | Genentech, Inc. | Inhibitors of angiopoietin-like 4 protein, combinations, and their use |
| US8604185B2 (en) | 2004-07-20 | 2013-12-10 | Genentech, Inc. | Inhibitors of angiopoietin-like 4 protein, combinations, and their use |
| TWI457133B (en) | 2005-12-13 | 2014-10-21 | Glaxosmithkline Biolog Sa | Novel composition |
| WO2007125621A1 (en) * | 2006-04-28 | 2007-11-08 | Osaka University | Novel use of gene whose expression is increased in hyperplastic pancreatic islet |
| US20100247528A1 (en) * | 2007-09-06 | 2010-09-30 | Kent Hunter | Arrays, kits and cancer characterization methods |
| AU2013201554B2 (en) * | 2008-09-03 | 2015-02-12 | Duke University | Genetic alterations in isocitrate dehydrogenase and other genes in malignant glioma |
| MX359574B (en) | 2008-09-03 | 2018-10-03 | Univ Johns Hopkins | GENETIC ALTERATIONS IN ISOCITRATE DEHYDROGENASE and OTHER GENES IN MALIGNANT GLIOMA. |
| AU2015202486B2 (en) * | 2008-09-03 | 2017-09-14 | Duke University | Genetic alterations in isocitrate dehydrogenase and other genes in malignant glioma |
| AU2011249782B2 (en) | 2010-05-06 | 2014-10-02 | Novartis Ag | Compositions and methods of use for therapeutic low density lipoprotein - related protein 6 (LRP6) multivalent antibodies |
| PH12012502406A1 (en) | 2010-05-06 | 2013-02-18 | Novartis Ag | Compositions and methods of use for therapeutic low density lipoprotein -related protein 6 (lrp6) antibodies |
| TW201323442A (en) | 2011-11-04 | 2013-06-16 | Novartis Ag | Low density lipoprotein-related protein 6 (LRP6)-half life extender constructs |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0874902A2 (en) * | 1996-01-11 | 1998-11-04 | Corixa Corporation | Compositions and methods for the treatment and diagnosis of breast cancer |
-
2000
- 2000-02-29 WO PCT/US2000/005431 patent/WO2000052165A2/en not_active Ceased
- 2000-02-29 AU AU33912/00A patent/AU3391200A/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| WO2000052165A3 (en) | 2001-02-15 |
| WO2000052165A2 (en) | 2000-09-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU1807401A (en) | Compositions and methods for therapy and diagnosis of breast cancer | |
| AU1656501A (en) | Compositions and methods for the therapy and diagnosis of prostate cancer | |
| AU7994200A (en) | Compositions and methods for therapy and diagnosis of prostate cancer | |
| PL354093A1 (en) | Compositions and methods for the therapy and diagnosis of lung cancer | |
| AU3391200A (en) | Compositions and methods for breast cancer therapy and diagnosis | |
| HUP0200763A2 (en) | Compositions for the treatment and diagnosis of breast cancer and methods for their use | |
| AU2001249549A1 (en) | Compositions and methods for the therapy and diagnosis of prostate cancer | |
| PL365244A1 (en) | Compositions and methods for the therapy and diagnosis of breast cancer | |
| AU2001268259A1 (en) | Compositions and methods for the therapy and diagnosis of colon cancer | |
| AU2001269766A1 (en) | Compositions and methods for the therapy and diagnosis of colon cancer | |
| AU2001261007A1 (en) | Compositions and methods for the therapy and diagnosis of lung cancer | |
| AU2002218770A1 (en) | Compositions and methods for the therapy and diagnosis of lung cancer | |
| AU2001280982A1 (en) | Compositions and methods for the therapy and diagnosis of colon cancer | |
| ZA982968B (en) | Compositions and methods for the treatment and diagnosis of breast cancer | |
| AU2002303219A1 (en) | Compositions and methods for the therapy and diagnosis of cancer | |
| AU2002246519A1 (en) | Compositions and methods for the therapy and diagnosis of colon cancer | |
| AU2001243349A1 (en) | Methods for the diagnosis and treatment of breast cancer | |
| AU2002313726A1 (en) | Compositions and methods for the therapy and diagnosis of breast cancer | |
| AU2001259062A1 (en) | Compositions and methods for the therapy and diagnosis of lung cancer | |
| AU5638400A (en) | Compositions and methods for the therapy and diagnosis of breast cancer | |
| AU2001290518A1 (en) | Compositions and methods for the therapy and diagnosis of colon cancer | |
| AU3177500A (en) | Proteins for diagnosis and treatment of breast cancer | |
| ZA200108256B (en) | Compositions and methods for the treatment and diagnosis of breast cancer. | |
| PL350863A1 (en) | Compositions and methods for the treatment and diagnosis of breast cancer | |
| AU2002253899A1 (en) | Compositions and methods for the therapy and diagnosis of breast cancer |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |